{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:34:15Z","timestamp":1793388855454,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bioorg.2021.104889","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T21:28:05Z","timestamp":1617830885000},"page":"104889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals"],"prefix":"10.1016","volume":"112","author":[{"given":"Le-Yun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Zhu","family":"Chigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Huan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Wu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2020","key":"10.1016\/j.bioorg.2021.104889_b0005","first-page":"497","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan China","volume":"395","author":"Huang","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2021.104889_b0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.12659\/MSM.924609","article-title":"Comparison of prevalence and associated factors of anxiety and depression among people affected by versus people unaffected by quarantine during the COVID-9 epidemic in Southwestern China","volume":"26","author":"Lei","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bioorg.2021.104889_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taaa021","article-title":"The reproductive number of COVID-19 is higher compared to SARS coronavirus","volume":"27","author":"Liu","year":"2020","journal-title":"J. Travel Med."},{"key":"10.1016\/j.bioorg.2021.104889_b0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bioorg.2021.104889_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17496-8","article-title":"Structural basis of RNA cap modification by SARS-CoV-2","volume":"11","author":"Viswanathan","year":"2020","journal-title":"Nat. Commun."},{"issue":"2020","key":"10.1016\/j.bioorg.2021.104889_b0030","first-page":"149","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2021.104889_b0035","doi-asserted-by":"crossref","first-page":"118336","DOI":"10.1016\/j.lfs.2020.118336","article-title":"COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic","volume":"261","author":"Bhavana","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2021.104889_b0040","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.3390\/ijms21155346","article-title":"Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations","volume":"21","author":"Grottesi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2021.104889_b0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104889_b0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF02174046","article-title":"Viral cysteine proteinases","volume":"6","author":"Gorbalenya","year":"1996","journal-title":"Perspect. Drug Discovery Des."},{"issue":"6","key":"10.1016\/j.bioorg.2021.104889_b0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","article-title":"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur","volume":"27","author":"Jin","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"14","key":"10.1016\/j.bioorg.2021.104889_b0060","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","article-title":"An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy","volume":"59","author":"Pillaiyar","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104889_b0065","first-page":"719","article-title":"Mouse model phenotypes provide information about human drug targets","volume":"5","author":"Robert","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bioorg.2021.104889_b0070","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/jcm9092800","article-title":"Impact of azithromycin and\/or hydroxychloroquine on hospital mortality in COVID-19","volume":"9","author":"Filippo","year":"2020","journal-title":"J. Clin. Med."},{"issue":"19","key":"10.1016\/j.bioorg.2021.104889_b0075","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl. J. Med."},{"issue":"24","key":"10.1016\/j.bioorg.2021.104889_b0080","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe COVID-19","volume":"382","author":"Grein","year":"2020","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.bioorg.2021.104889_b0085","doi-asserted-by":"crossref","first-page":"105631","DOI":"10.1016\/j.ejps.2020.105631","article-title":"Clinical outcomes and plasma concentrations of baloxavir marboxil and favipiravir in COVID-19 patients: an exploratory randomized, controlled trial","volume":"157","author":"Lou","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7019","key":"10.1016\/j.bioorg.2021.104889_b0090","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nature03197","article-title":"Virtual screening of chemical libraries","volume":"432","author":"Shoichet","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.104889_b0095","first-page":"1","article-title":"Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors","author":"Bhardwaj","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2021.104889_b0100","doi-asserted-by":"crossref","first-page":"104117","DOI":"10.1016\/j.compbiomed.2020.104117","article-title":"Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs","volume":"128","author":"Bhardwaj","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bioorg.2021.104889_b0105","doi-asserted-by":"crossref","first-page":"128933","DOI":"10.1016\/j.foodchem.2020.128933","article-title":"An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2","volume":"346","author":"Sharma","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.bioorg.2021.104889_b0110","doi-asserted-by":"crossref","first-page":"110094","DOI":"10.1016\/j.jtbi.2019.110094","article-title":"Elimination of bitter-off taste of stevioside through structure modification and computational interventions","volume":"486","author":"Bhardwaj","year":"2020","journal-title":"J. Theor. Biol."},{"issue":"17","key":"10.1016\/j.bioorg.2021.104889_b0115","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1080\/07391102.2019.1696709","article-title":"Natural analogues inhibiting selective cyclin-dependent kinase protein isoforms: a computational perspective","volume":"38","author":"Singh","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2021.104889_b0120","doi-asserted-by":"crossref","first-page":"105494","DOI":"10.1016\/j.cmpb.2020.105494","article-title":"Structural based study to identify new potential inhibitors for dual specificity tyrosine-phosphorylation- regulated kinase","volume":"194","author":"Bhardwaj","year":"2020","journal-title":"Comput Meth. Programs Biomed."},{"issue":"1","key":"10.1016\/j.bioorg.2021.104889_b0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ygeno.2020.10.001","article-title":"Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants","volume":"113","author":"Singh","year":"2021","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.bioorg.2021.104889_b0130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.antiviral.2011.08.001","article-title":"Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease","volume":"92","author":"Zhu","year":"2011","journal-title":"Antiviral Res."},{"issue":"36","key":"10.1016\/j.bioorg.2021.104889_b0135","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1016\/j.tet.2006.06.052","article-title":"Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitors","volume":"62","author":"Sydnes","year":"2006","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2021.104889_b0140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejmech.2013.07.037","article-title":"Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies","volume":"68","author":"Thanigaimalai","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2021.104889_b0145","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bmc.2014.12.028","article-title":"Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors","volume":"23","author":"Shimamoto","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104889_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abe0751","article-title":"Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mproand cathepsin L","volume":"6","author":"Sacco","year":"2020","journal-title":"Sci. Adv."},{"issue":"6497","key":"10.1016\/j.bioorg.2021.104889_b0155","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioorg.2021.104889_b0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-83229-6","article-title":"Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2","volume":"11","author":"Weglarz-Tomczak","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bioorg.2021.104889_b0165","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jmb.2006.11.073","article-title":"Production of authentic SARS-CoV M-pro with enhanced activity: Application as a novel tag-cleavage endopeptidase for protein overproduction","volume":"366","author":"Xue","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"7811","key":"10.1016\/j.bioorg.2021.104889_b0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.104889_b0175","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","article-title":"Alpha-ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2021.104889_b0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/acsmedchemlett.5b00495","article-title":"Triazolylthioacetamide: A valid scaffold for the development of New Delhi Metallo-\u03b2-Lactmase-1 (NDM-1) Inhibitors","volume":"7","author":"Zhai","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2021.104889_b0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/acsmedchemlett.7b00548","article-title":"Rhodanine as a potent scaffold for the development of broad-spectrum Metallo-\u03b2-lactamase Inhibitors","volume":"9","author":"Xiang","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2021.104889_b0190","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acsmedchemlett.7b00058","article-title":"Carbamylmethyl mercaptoacetate thioether: a novel scaffold for the development of L1 metallo-\u03b2-lactamase Inhibitors","volume":"8","author":"Chang","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104889_b0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1039\/C9MD00455F","article-title":"Meta-substituted benzenesulfonamide: A potent scaffold for the development of metallo-beta-lactamase ImiS inhibitors","volume":"11","author":"Liu","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104889_b0200","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/cmdc.201402249","article-title":"Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi Metallo-beta-Lactamase-1 (NDM-1)","volume":"9","author":"Zhang","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2021.104889_b0205","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.4155\/fmc-2019-0008","article-title":"The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-beta-lactamases inhibition","volume":"11","author":"Chen","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104889_b0210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bioorg.2018.11.035","article-title":"Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-beta-lactamase-1 in vitro and in vivo","volume":"84","author":"Su","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2021.104889_b0215","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2021.104889_b0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ab.2011.05.029","article-title":"Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis","volume":"416","author":"Copeland","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2021.104889_b0225","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1021\/ja8082285","article-title":"Covalent protein labeling based on noncatalytic beta-Lactamase and a designed FRET substrate","volume":"131","author":"Mizukami","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.bioorg.2021.104889_b0230","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/acsptsci.0c00130","article-title":"Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin are nonspecific promiscuous SARS-CoV-2 main protease Inhibitors","volume":"3","author":"Ma","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2021.104889_b0235","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tiv.2006.12.014","article-title":"Ebselen and diorganylchalcogenides decrease in vitro glutamate uptake by RAT brain slices: Prevention by DTT and GSH","volume":"21","author":"Moretto","year":"2007","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bioorg.2021.104889_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-69337-9","article-title":"Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates","volume":"10","author":"Yoshino","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2021.104889_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-77794-5","article-title":"Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"10","author":"Shitrit","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bioorg.2021.104889_b0250","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bioorg.2021.104889_b0255","first-page":"201","article-title":"The behavior and significance of slow-binding enzyme inhibitors","volume":"61","author":"Morrison","year":"1988","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.bioorg.2021.104889_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.02221-18","article-title":"Validating enterovirus D68\u20132A(pro) as an antiviral drug target and the discovery of telaprevir as a potent D68\u20132A(pro) Inhibitor","volume":"93","author":"Musharrafieh","year":"2019","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.bioorg.2021.104889_b0265","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.3390\/ijms21113793","article-title":"Garcia Vallve, Prediction of novel inhibitors of the main protease (M-pro) of SARS-CoV-2 through consensus docking and drug reposition","volume":"21","author":"Gimeno","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2021.104889_b0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/pro.2733","article-title":"Covalent docking using autodock: Two-point attractor and flexible side chain methods","volume":"25","author":"Bianco","year":"2016","journal-title":"Protein Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821002662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821002662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:17:12Z","timestamp":1758615432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821002662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":54,"alternative-id":["S0045206821002662"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104889","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104889"}}